Name
Tyra Biosciences, Inc.
Company Description
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions.
Featured Exhibitor
Yes
First Time Exhibitor
Yes
Address (city, state, and country will display online and in-print)
Carlsbad, CA
United States
LinkedIn

Badges

Featured Exhibitor